Navigation Links
Genelex Corporation Defends Consumers' Right to Obtain DNA Information:
Date:1/9/2008

Company founder urges government to apply rating system to home DNA tests

to protect against 'unscrupulous and misrepresented tests'

WASHINGTON, Jan. 9 /PRNewswire/ -- Should consumers have a right to obtain information regarding their personal health through home DNA tests? According to Genelex founder, Howard Coleman, the answer is: absolutely. "I agree with scientific opinion that tens of thousands of lives can be saved each year by DNA testing that reveal potential adverse drug reactions."

Coleman believes that such specific and accurate information will be the foundation for personalized medical treatment in the 21st century. "One pill does not fit all," Coleman states.

Genelex Corporation sells home DNA tests that analyze an individual's ability to process the most commonly prescribed and over the counter medication. "More than half the population has DNA alterations that can render many medications ineffective, or worse, trigger side effects that can prove to be fatal," Coleman said. Some common medications depend upon an individual's DNA for effectiveness and safety include Tamoxifen, Coumadin, Codeine and many others.

Coleman testified Tuesday before the President's Council of Advisors on Science and Technology in Washington DC (http://www.ostp.gov/PCAST/pcast.html). While Coleman supports consumers' access to home DNA tests, he shares some of the Council's concerns that there are unscrupulous companies that don't provide accurate or useful testing. Coleman suggested that companies who sell home DNA tests should, in cooperation with government agencies, implement a rating system that describes the certainty of their predictive value. "People have a fundamental right to learn and control this information. A rating system would allow people to decide if a particular test meets their needs."

Genelex Corporation was founded in 1987, and provides a program for comprehensive personalized medication management consisting of DNA testing and software for interpreting the test results based on all of the medicines a patient is taking.

For further information about Genelex go to http://www.Genelex.com. To contact Howard Coleman, call (206) 714-6393.


'/>"/>
SOURCE Genelex Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
2. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
3. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
4. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
5. BioElectronics Corporation Announces Singapore and Malaysia Sales
6. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
7. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
8. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
9. Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
10. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
11. Enova Medical Launches Exos Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... , ... The new and improved Oakton® pocket testers, from Cole-Parmer, stand up ... a new cap design that is versatile, functional and leakproof. They are ideal for ... water quality. , The Oakton pocket testers have many user-friendly and functional features. An ...
(Date:9/19/2017)... Sept. 19, 2017 ValGenesis Inc., the global ... pleased to announce the strategic partnership with VTI Life ... with validation services using the latest technology available in ... provide clients with efficient and cost-effective validation services using ... for the ValGenesis VLMS system. ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... technologies, today announced a partnership with Cytena GmbH to launch the CloneSelectâ„¢ Single-Cell ... real-time image analysis to isolate single cells and provide visual documentation of monoclonality ...
(Date:9/19/2017)... ... 2017 , ... Band-LOK, LLC, an orthopedic medical device innovation ... patents have been allowed by the USPTO on the proprietary Tether Clamp and ... explore additional clinically-relevant designs for both the implants and the instrumentation. I ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/30/2017)... -- The research team of The Hong Kong Polytechnic ... by adopting ground breaking 3D fingerprint minutiae recovery and matching technology, ... accuracy for use in identification, crime investigation, immigration control, security of ... ... A research team led by Dr ...
Breaking Biology News(10 mins):